nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—Nandrolone decanoate—MAOA—conduct disorder	0.0388	0.454	CrCbGaD
Progesterone—Testosterone Propionate—COMT—conduct disorder	0.0352	0.412	CrCbGaD
Progesterone—Testosterone—MAOA—conduct disorder	0.0115	0.135	CrCbGaD
Progesterone—CYP17A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0104	0.0114	CbGpPWpGaD
Progesterone—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00895	0.00979	CbGpPWpGaD
Progesterone—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00835	0.00913	CbGpPWpGaD
Progesterone—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.00824	0.00901	CbGpPWpGaD
Progesterone—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.00802	0.00877	CbGpPWpGaD
Progesterone—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00775	0.00847	CbGpPWpGaD
Progesterone—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.00674	0.00737	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00644	0.00704	CbGpPWpGaD
Progesterone—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0062	0.00678	CbGpPWpGaD
Progesterone—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00606	0.00663	CbGpPWpGaD
Progesterone—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00598	0.00654	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00558	0.0061	CbGpPWpGaD
Progesterone—CYP17A1—Biological oxidations—COMT—conduct disorder	0.00556	0.00608	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00552	0.00604	CbGpPWpGaD
Progesterone—CYP17A1—Biological oxidations—MAOA—conduct disorder	0.00552	0.00603	CbGpPWpGaD
Progesterone—CYP17A1—Metapathway biotransformation—COMT—conduct disorder	0.00548	0.00599	CbGpPWpGaD
Progesterone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00547	0.00598	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00538	0.00588	CbGpPWpGaD
Progesterone—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00525	0.00574	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00501	0.00548	CbGpPWpGaD
Progesterone—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00501	0.00548	CbGpPWpGaD
Progesterone—AR—FOXA1 transcription factor network—EP300—conduct disorder	0.00499	0.00546	CbGpPWpGaD
Progesterone—PGR—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00486	0.00531	CbGpPWpGaD
Progesterone—AR—Notch-mediated HES/HEY network—EP300—conduct disorder	0.00474	0.00518	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00473	0.00517	CbGpPWpGaD
Progesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—conduct disorder	0.00435	0.00476	CbGpPWpGaD
Progesterone—AR—Regulation of Androgen receptor activity—EP300—conduct disorder	0.0043	0.00471	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00424	0.00463	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CGA—conduct disorder	0.0042	0.0046	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0042	0.00459	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.00412	0.0045	CbGpPWpGaD
Progesterone—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.00403	0.00441	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00399	0.00437	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00399	0.00437	CbGpPWpGaD
Progesterone—ESR1—FOXM1 transcription factor network—EP300—conduct disorder	0.00399	0.00437	CbGpPWpGaD
Progesterone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00395	0.00432	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—POLR3A—conduct disorder	0.00391	0.00428	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—DRD4—conduct disorder	0.00389	0.00425	CbGpPWpGaD
Progesterone—ESR1—FOXA1 transcription factor network—EP300—conduct disorder	0.00385	0.00421	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00384	0.0042	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0038	0.00415	CbGpPWpGaD
Progesterone—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00373	0.00408	CbGpPWpGaD
Progesterone—ESR1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00371	0.00406	CbGpPWpGaD
Progesterone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00361	0.00394	CbGpPWpGaD
Progesterone—SLC22A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00353	0.00386	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00342	0.00374	CbGpPWpGaD
Progesterone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00342	0.00374	CbGpPWpGaD
Progesterone—NR3C1—Regulation of Androgen receptor activity—EP300—conduct disorder	0.00326	0.00357	CbGpPWpGaD
Progesterone—CYP1B1—Biological oxidations—COMT—conduct disorder	0.00324	0.00355	CbGpPWpGaD
Progesterone—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.00322	0.00352	CbGpPWpGaD
Progesterone—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.0032	0.0035	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00319	0.00348	CbGpPWpGaD
Progesterone—NR3C1—Circadian Clock—EP300—conduct disorder	0.00317	0.00347	CbGpPWpGaD
Progesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.0031	0.00338	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00309	0.00338	CbGpPWpGaD
Progesterone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00306	0.00335	CbGpPWpGaD
Progesterone—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00305	0.00334	CbGpPWpGaD
Progesterone—ESR1—ATF-2 transcription factor network—EP300—conduct disorder	0.00304	0.00333	CbGpPWpGaD
Progesterone—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00292	0.0032	CbGpPWpGaD
Progesterone—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.0029	0.00317	CbGpPWpGaD
Progesterone—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00288	0.00315	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—CGA—conduct disorder	0.00287	0.00314	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00285	0.00312	CbGpPWpGaD
Progesterone—ESR1—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00285	0.00312	CbGpPWpGaD
Progesterone—AR—Androgen receptor signaling pathway—EP300—conduct disorder	0.00284	0.00311	CbGpPWpGaD
Progesterone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00281	0.00307	CbGpPWpGaD
Progesterone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00278	0.00305	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00276	0.00302	CbGpPWpGaD
Progesterone—CYP2A6—Biological oxidations—COMT—conduct disorder	0.00268	0.00293	CbGpPWpGaD
Progesterone—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00266	0.00291	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—EP300—conduct disorder	0.00265	0.0029	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—EP300—conduct disorder	0.00261	0.00286	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0026	0.00284	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00259	0.00283	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00257	0.00281	CbGpPWpGaD
Progesterone—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00254	0.00278	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00246	0.00269	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00246	0.00269	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00241	0.00264	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00239	0.00262	CbGpPWpGaD
Progesterone—PGR—Gene Expression—POLR3A—conduct disorder	0.00238	0.00261	CbGpPWpGaD
Progesterone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00238	0.0026	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CGA—conduct disorder	0.00238	0.0026	CbGpPWpGaD
Progesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00236	0.00258	CbGpPWpGaD
Progesterone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00235	0.00257	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—DRD4—conduct disorder	0.00235	0.00257	CbGpPWpGaD
Progesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00233	0.00254	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—EP300—conduct disorder	0.0023	0.00252	CbGpPWpGaD
Progesterone—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00221	0.00242	CbGpPWpGaD
Progesterone—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00218	0.00238	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CGA—conduct disorder	0.00216	0.00236	CbGpPWpGaD
Progesterone—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00211	0.00231	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—CGA—conduct disorder	0.00211	0.0023	CbGpPWpGaD
Progesterone—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.0021	0.00229	CbGpPWpGaD
Progesterone—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00208	0.00228	CbGpPWpGaD
Progesterone—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00206	0.00226	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00202	0.00221	CbGpPWpGaD
Progesterone—CYP1A1—Biological oxidations—COMT—conduct disorder	0.002	0.00218	CbGpPWpGaD
Progesterone—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00198	0.00217	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—COMT—conduct disorder	0.00198	0.00217	CbGpPWpGaD
Progesterone—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00197	0.00215	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00197	0.00215	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00186	0.00204	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—COMT—conduct disorder	0.00185	0.00202	CbGpPWpGaD
Progesterone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00184	0.00201	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00183	0.00201	CbGpPWpGaD
Progesterone—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00183	0.002	CbGpPWpGaD
Progesterone—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00182	0.00199	CbGpPWpGaD
Progesterone—AR—Gene Expression—POLR3A—conduct disorder	0.00182	0.00198	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00181	0.00198	CbGpPWpGaD
Progesterone—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00181	0.00197	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CGA—conduct disorder	0.00176	0.00193	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0017	0.00186	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CGA—conduct disorder	0.00169	0.00185	CbGpPWpGaD
Progesterone—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00163	0.00179	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CGA—conduct disorder	0.00163	0.00178	CbGpPWpGaD
Progesterone—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00162	0.00177	CbGpPWpGaD
Progesterone—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00161	0.00176	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00157	0.00171	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00157	0.00171	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00156	0.0017	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00154	0.00169	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—HTR2A—conduct disorder	0.00154	0.00168	CbGpPWpGaD
Progesterone—CYP2D6—Biological oxidations—COMT—conduct disorder	0.0015	0.00164	CbGpPWpGaD
Progesterone—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00149	0.00163	CbGpPWpGaD
Progesterone—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00149	0.00163	CbGpPWpGaD
Progesterone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00148	0.00162	CbGpPWpGaD
Progesterone—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00148	0.00162	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00147	0.00161	CbGpPWpGaD
Progesterone—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00147	0.00161	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00143	0.00157	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—POLR3A—conduct disorder	0.0014	0.00153	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00139	0.00152	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—POLR3A—conduct disorder	0.00138	0.00151	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00138	0.00151	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—DRD4—conduct disorder	0.00133	0.00145	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—WASF1—conduct disorder	0.0013	0.00143	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—COMT—conduct disorder	0.00129	0.00142	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—MAOA—conduct disorder	0.00129	0.00141	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CGA—conduct disorder	0.00127	0.00139	CbGpPWpGaD
Progesterone—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00127	0.00139	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CGA—conduct disorder	0.00127	0.00139	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00127	0.00139	CbGpPWpGaD
Progesterone—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00126	0.00138	CbGpPWpGaD
Progesterone—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00126	0.00137	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00125	0.00136	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CGA—conduct disorder	0.00123	0.00134	CbGpPWpGaD
Progesterone—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00122	0.00134	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00121	0.00132	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—DRD4—conduct disorder	0.00121	0.00132	CbGpPWpGaD
Progesterone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.0012	0.00131	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00119	0.0013	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CGA—conduct disorder	0.00111	0.00121	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CGA—conduct disorder	0.00111	0.00121	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00108	0.00118	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CGA—conduct disorder	0.00103	0.00113	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—WASF1—conduct disorder	0.00102	0.00112	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CGA—conduct disorder	0.00102	0.00111	CbGpPWpGaD
Progesterone—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000983	0.00107	CbGpPWpGaD
Progesterone—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000976	0.00107	CbGpPWpGaD
Progesterone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000969	0.00106	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CGA—conduct disorder	0.000955	0.00104	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—COMT—conduct disorder	0.00095	0.00104	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—MAOA—conduct disorder	0.000944	0.00103	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000915	0.001	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—DRD4—conduct disorder	0.000911	0.000996	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—HTR2A—conduct disorder	0.000868	0.000949	CbGpPWpGaD
Progesterone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.000826	0.000903	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CGA—conduct disorder	0.000801	0.000875	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—COMT—conduct disorder	0.000796	0.00087	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—MAOA—conduct disorder	0.00079	0.000864	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HTR2A—conduct disorder	0.000788	0.000862	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—WASF1—conduct disorder	0.000765	0.000837	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—COMT—conduct disorder	0.000763	0.000834	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—MAOA—conduct disorder	0.000758	0.000829	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CGA—conduct disorder	0.000756	0.000827	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000735	0.000803	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—DRD4—conduct disorder	0.000714	0.00078	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CGA—conduct disorder	0.000693	0.000758	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000629	0.000688	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CGA—conduct disorder	0.000619	0.000677	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CGA—conduct disorder	0.000604	0.000661	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HTR2A—conduct disorder	0.000594	0.00065	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—COMT—conduct disorder	0.000573	0.000627	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CGA—conduct disorder	0.000569	0.000623	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—MAOA—conduct disorder	0.000569	0.000622	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CGA—conduct disorder	0.000564	0.000617	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—EP300—conduct disorder	0.000555	0.000607	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—COMT—conduct disorder	0.000554	0.000606	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000552	0.000604	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—MAOA—conduct disorder	0.000551	0.000602	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—DRD4—conduct disorder	0.000535	0.000585	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000534	0.000584	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—COMT—conduct disorder	0.0005	0.000547	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—COMT—conduct disorder	0.000499	0.000546	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—MAOA—conduct disorder	0.000496	0.000543	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—MAOA—conduct disorder	0.000496	0.000542	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CGA—conduct disorder	0.000482	0.000527	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HTR2A—conduct disorder	0.000466	0.000509	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—COMT—conduct disorder	0.000465	0.000509	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—MAOA—conduct disorder	0.000462	0.000505	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—COMT—conduct disorder	0.000458	0.000501	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—MAOA—conduct disorder	0.000455	0.000498	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—EP300—conduct disorder	0.000408	0.000446	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CGA—conduct disorder	0.000372	0.000407	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—COMT—conduct disorder	0.000361	0.000395	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—MAOA—conduct disorder	0.000359	0.000392	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HTR2A—conduct disorder	0.000349	0.000381	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—COMT—conduct disorder	0.000341	0.000373	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—EP300—conduct disorder	0.000341	0.000373	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—MAOA—conduct disorder	0.000339	0.000371	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000329	0.00036	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—EP300—conduct disorder	0.000327	0.000358	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EP300—conduct disorder	0.000315	0.000344	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—COMT—conduct disorder	0.000313	0.000342	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—MAOA—conduct disorder	0.000311	0.00034	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000301	0.00033	CbGpPWpGaD
Progesterone—ABCC1—Disease—EP300—conduct disorder	0.000294	0.000321	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—COMT—conduct disorder	0.000279	0.000306	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—MAOA—conduct disorder	0.000277	0.000303	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—COMT—conduct disorder	0.000273	0.000298	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—MAOA—conduct disorder	0.000271	0.000296	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000269	0.000294	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—COMT—conduct disorder	0.000257	0.000281	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—MAOA—conduct disorder	0.000255	0.000279	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—COMT—conduct disorder	0.000255	0.000279	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—MAOA—conduct disorder	0.000253	0.000277	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EP300—conduct disorder	0.000247	0.00027	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—EP300—conduct disorder	0.000246	0.000269	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000245	0.000268	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—EP300—conduct disorder	0.000238	0.00026	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—COMT—conduct disorder	0.000218	0.000238	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—MAOA—conduct disorder	0.000216	0.000236	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—EP300—conduct disorder	0.000214	0.000234	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—EP300—conduct disorder	0.000214	0.000234	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00021	0.000229	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—EP300—conduct disorder	0.0002	0.000218	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—EP300—conduct disorder	0.000197	0.000215	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EP300—conduct disorder	0.000185	0.000202	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—COMT—conduct disorder	0.000168	0.000184	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MAOA—conduct disorder	0.000167	0.000182	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—EP300—conduct disorder	0.000155	0.000169	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—EP300—conduct disorder	0.000146	0.00016	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—EP300—conduct disorder	0.000134	0.000147	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—EP300—conduct disorder	0.00012	0.000131	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—EP300—conduct disorder	0.000117	0.000128	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—EP300—conduct disorder	0.00011	0.000121	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—EP300—conduct disorder	0.000109	0.000119	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—EP300—conduct disorder	9.34e-05	0.000102	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—EP300—conduct disorder	7.21e-05	7.88e-05	CbGpPWpGaD
